Importantly, astrocyte and microglia activation is a key process during MS as these glial cells contribute to brain endothelial inflammation and dysfunction via secretion of pro-inflammatory mediators, including TGF-β1 and IL-1β36–39,62. Here, TGFB1 is linked to myeloid sarcoma.